N

Navega Therapeutics

8 employees

Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Health Care
Gene Therapy
Pain Management
Therapeutics
Biopharma

Date founded

2018

Funding rounds raised

Total raised

$3.8M

from 4 investors over 4 rounds

N

Navega Therapeutics raised $3.8M on June 1, 2021

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

N

Navega Therapeutics raised undisclosed on January 1, 2021

Investors: Creative Destruction Lab

N

Navega Therapeutics raised $912K on September 26, 2019

Investors: National Cancer Institute and National Institute of Neurological Disorders and Stroke (NINDS)

FAQ